[1]
C. Spagnoli, “Continuitiy of care with ataluren in Duchenne Muscular Dystrophy patients with nonsense mutations after loss of ambulation. Personal experience”, MYO, vol. 42, no. 4, pp. 118–122, Dec. 2023.